---
title: "Bain Capital Life Sciences Fund IV, L.P. — Ownership Dossier"
canonical: https://whiteintel.dev/entity/080bcfe2-2bc6-53ce-886e-a27c277f0d4d
json: https://whiteintel.dev/api/public/dossier/080bcfe2-2bc6-53ce-886e-a27c277f0d4d
identifier: sec:0001996979
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Bain Capital Life Sciences Fund IV, L.P.

**Type:** Person  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001996979`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/080bcfe2-2bc6-53ce-886e-a27c277f0d4d  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/080bcfe2-2bc6-53ce-886e-a27c277f0d4d  

## Ownership & control

### Holdings / subsidiaries

- **Olema Pharmaceuticals, Inc.** (10% owner) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729
- **Olema Pharmaceuticals, Inc.** (10% owner) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729
- **KAILERA THERAPEUTICS, INC.** (tenpercentowner) — https://whiteintel.dev/entity/a374bc29-832b-57f1-ae15-b2c2c939a417
- **Olema Pharmaceuticals, Inc.** (tenpercentowner) — https://whiteintel.dev/entity/63f4ec36-6123-58df-98c8-2a1210390729

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Bain Capital Life Sciences Fund IV, L.P.**. Human view: https://whiteintel.dev/entity/080bcfe2-2bc6-53ce-886e-a27c277f0d4d · Structured JSON: https://whiteintel.dev/api/public/dossier/080bcfe2-2bc6-53ce-886e-a27c277f0d4d._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._